Giant Meckel's Diverticulum Mimicking Crohn's Disease: Double-Stricture Deception [0.03%]
巨大梅克尔憩室模仿克罗恩病：双狭窄欺骗现象
Yongli Li,Tian He,Ping Wan et al.
Yongli Li et al.
Characterising the Economic Burden of Functional Dyspepsia: A Cost-of-Illness Study of Direct and Indirect Costs [0.03%]
一项关于直接和间接经济损失的疾病负担研究：功能性消化不良经济负担的特点
Daan H C A Bosch,Brigitte A B Essers,Abraham B Beckers et al.
Daan H C A Bosch et al.
Background: Functional dyspepsia (FD) is a prevalent disorder of gut-brain interaction (DGBI) and is associated with substantial impact on health care utilisation. However, analyses examining patient-specific characterist...
Randomized Controlled Trial
United European gastroenterology journal. 2026 Sep;14(7):e70257. DOI:10.1002/ueg2.70257 2026
Dedicated Endoscopy for Barrett's Oesophagus With Higher Dysplasia Yield May Reduce Seattle Protocol Biopsies: Results From UK Multicentre Study [0.03%]
专门针对巴雷特食管的内镜检查（更高的异型增生阳性率）可减少西雅图协议活检：英国多中心研究结果
Champika Gamakaranage,James Britton,Elizabeth Ratcliffe et al.
Champika Gamakaranage et al.
Background: Dedicated service for Barrett's oesophagus (BO) surveillance may be more effective than conventional service, according to some single centre studies. ...
Multicenter Study
United European gastroenterology journal. 2026 Sep;14(7):e70270. DOI:10.1002/ueg2.70270 2026
Global Prevalence of Self-Reported Alarm Features in the General Population and Among Individuals With Disorders of Gut-Brain Interaction-Results From the Rome Foundation Global Epidemiology Study [0.03%]
来自罗马基金会全球流行病学研究的普通人群和肠道脑交互障碍患者中自我报告警报特征的全球患病率
Jessica Sjölund,Jóhann P Hreinsson,Brian E Lacy et al.
Jessica Sjölund et al.
Background: Data on the global prevalence of alarm features in the general population and among individuals with disorders of gut-brain interaction (DGBI) are limited. ...
Diagnosing Disorders of the Gut-Brain Interaction: When to Sound the Alarm? [0.03%]
胃肠病理性相互作用的诊断：何时该敲响警钟？
Daniel Keszthelyi
Daniel Keszthelyi
Hidden in the Biliary Tree: Low-Grade Fibromyxoid Sarcoma of the Common Bile Duct [0.03%]
胆总管低级别黏液纤维瘤样肉瘤的内镜超声诊断及内镜治疗
Vladimir Prochazka,Jakub Vlazny,Tomas Andrasina et al.
Vladimir Prochazka et al.
Clinical and Mechanistic Association Between Intestinal Permeability and the Gut Microbiome in Cirrhosis: Role of Phascolarctobacterium [0.03%]
肝硬化肠道通透性与肠道菌群的临床及机制关联：Phascolarctobacterium的作用
Rosa Haller,Nicole Feldbacher,Stefan Fürst et al.
Rosa Haller et al.
Background: In patients with liver cirrhosis, intestinal permeability and the composition of the gut microbiome are altered. Thus, the microbiome might be a therapeutic target for the treatment of both liver diseases and ...
Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites [0.03%]
治疗前血清白蛋白浓度可预测肝硬化伴腹水患者长期补充白蛋白的临床获益
Enrico Pompili,Giacomo Zaccherini,Silvia Nardelli et al.
Enrico Pompili et al.
Background and aims: The benefit of long-term albumin (LTA) in improving survival and reducing complications in patients with cirrhosis and ascites is not consistently observed across studies, possibly reflecting differen...
Randomized Controlled Trial
United European gastroenterology journal. 2026 Jul;14(6):e70258. DOI:10.1002/ueg2.70258 2026
Albrecht Neesse
Albrecht Neesse
Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real-World Cohort Study [0.03%]
代谢综合征在炎症性肠病中的负担和临床影响：真实世界队列研究
Raseen Tariq,Kavin Parmar,Mahima Desai et al.
Raseen Tariq et al.
Background: Metabolic syndrome (MetS) and its cardiometabolic complications are recognized in inflammatory bowel disease (IBD); however, longitudinal trends and their impact on outcomes remain incompletely defined. We aim...